3D-QSAR, HQSAR, molecular docking, and new compound design study of 1,3,6-trisubstituted 1,4-diazepan-7-ones as human KLK7 inhibitors
Authors:
- 5 May 2020
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 29 (6) , 1012-1029
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7Bioorganic & Medicinal Chemistry Letters, 2019
- FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasetsData in Brief, 2019
- 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective InhibitorsRecent Patents on Anti-Cancer Drug Discovery, 2017
- Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum CorneumJournal of Investigative Dermatology, 2017
- Quantitative structure–activity relationships (HQSAR, CoMFA, and CoMSIA) studies for COX-2 selective inhibitorsJournal of Biomolecular Structure and Dynamics, 2016
- Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7European Journal of Medicinal Chemistry, 2015
- LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent InteractionMolecular Biology of the Cell, 2007
- New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene–environment interactionsJournal of Allergy and Clinical Immunology, 2006
- Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selectionJournal of Computer-Aided Molecular Design, 2002
- Beware of q2!Journal of Molecular Graphics and Modelling, 2002